Literature DB >> 12522438

Selectively replicating viral vectors.

John Nemunaitis1, Jeffrey Edelman.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12522438     DOI： 10.1038/sj.cgt.7700547

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN： 0929-1903            Impact factor:   5.987


× No keyword cloud information.
  9 in total

1.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

3.  A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters.

Authors:  Feng Liu; Kaya Xu; Hua Yang; Yuming Li; Jian Liu; Jixiang Wang; Zhizhong Guan
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

4.  Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas.

Authors:  Xueqing Lun; Wenqing Yang; Tommy Alain; Zhong-Qiao Shi; Huong Muzik; John W Barrett; Grant McFadden; John Bell; Mark G Hamilton; Donna L Senger; Peter A Forsyth
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

5.  Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma.

Authors:  Monique H Verheije; Martine L M Lamfers; Thomas Würdinger; Guy C M Grinwis; Winald R Gerritsen; Victor W van Beusechem; Peter J M Rottier
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

6.  An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.

Authors:  D L Lichtenstein; J F Spencer; K Doronin; D Patra; J M Meyer; E V Shashkova; M Kuppuswamy; D Dhar; M A Thomas; A E Tollefson; L A Zumstein; W S M Wold; K Toth
Journal:  Cancer Gene Ther       Date:  2009-02-06       Impact factor: 5.987

7.  Characterization of an Oncolytic Adenovirus Vector Constructed to Target the cMet Receptor.

Authors:  Hany I Sakr; David T Coleman; James A Cardelli; J Michael Mathis
Journal:  Oncolytic Virother       Date:  2015

8.  Overexpression of LncRNA SNHG1 Were Suitable for Oncolytic Adenoviruse H101 Therapy in Oral Squamous-Cell Carcinoma.

Authors:  Xin Wang; Song Yang; Xuechao Lv; Lina Wang; Chunmei Li
Journal:  Onco Targets Ther       Date:  2020-12-21       Impact factor: 4.147

9.  Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice.

Authors:  Anna Israyelyan; Vladimir N Chouljenko; Abolghasem Baghian; Andrew T David; Michael T Kearney; Konstantin G Kousoulas
Journal:  Virol J       Date:  2008-06-02       Impact factor: 4.099
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.